compounded semaglutide fda warning november 2025 issued 25 letters to telehealth companies for false and misleading claims about GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of July 29, 2024: FDA issued

The function of the fatty-acid oxidation pathway in fibroblast cultures and biomarkers for abnormalities in non-mitochondrial fatty-acid metabolism were not consistently abnormal across the subgroup of ASD children, consistent with the notion that the abnormalities in fatty-acid metabolism found in this subgroup of children with ASD were secondary to TCAC abnormalities

If you take these and you feel worse, then maybe you have low glutathione, or maybe you have high levels of oxidative stress from somewhere

Xu D, Ran Q, Xiang Y, Jiang L, Smith BM, Bou-Abdallah F, et al

The GLP-1 antibody (ab 89390) targets the amidated C-terminus of the peptide, thereby quantifying total GLP-1 (intact as well as N-terminally truncated forms of GLP-1) (57)